secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2023-03-03T23:59:59+00:00
Accession:  0001558370-23-002778
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio shareholders authorize board to effect reverse stock split up to 20:1
--------------------------------------------------------------------------------

- Holders of ~62.2% voting power signed written consent approving reverse stock split.
- Board authorized to set ratio between 5:1 and 20:1, with split to occur before Jan 31, 2024.
- Consent signed by holders of 22,630,620 common shares and 250,000 Class A Preferred shares.
- Board also approved the reverse stock split and amendment to certificate of incorporation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000155837023002778/0001558370-23-002778-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000155837023002778/tmb-20230303x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-002778

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer